BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Lactobacillus Sps in Reducing the Risk of Diabetes in High-Fat Diet-Induced Diabetic Mice by Modulating the Gut Microbiome and Inhibiting Key Digestive Enzymes Associated with Diabetes. ✅
Biology (Biology (Basel) ) Vol: 10 Issue 4 Pages: Pub: 2021 Apr 20 Epub: 2021 Apr 20 Authors Gulnaz A , Nadeem J , Han JH , Lew LC , Son JD , Park YH , Rather IA , Hor YY , |
|
|
Lactobacillus sakei modulates mule duck microbiota in ileum and ceca during overfeeding. ✅
Go to Publication ✅
Poultry science (Poult Sci ) Vol: 93 Issue 4 Pages: 916-25 Pub: 2014 Apr Epub: Authors Vasaï F , Ricaud KB , Cauquil L , Daniel P , Peillod C , Gontier K , Tizaoui A , Bouchez O , Combes S , Davail S , |
|
|
Lactobacillus sakei ADM14 Induces Anti-Obesity Effects and Changes in Gut Microbiome in High-Fat Diet-Induced Obese Mice. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 12 Issue 12 Pages: Pub: 2020 Nov 30 Epub: 2020 Nov 30 Authors Won SM , Chen S , Lee SY , Lee KE , Park KW , Yoon JH , |
|
|
Lactobacillus sakei ADM14 Induces Anti-Obesity Effects and Changes in Gut Microbiome in High-Fat Diet-Induced Obese Mice. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 12 Issue 12 Pages: Pub: 2020 Nov 30 Epub: 2020 Nov 30 Authors Won SM , Chen S , Lee SY , Lee KE , Park KW , Yoon JH , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
